MPX Receives Final Court Approval for Arrangement with iAnthus
18 janv. 2019 17h00 HE
|
MPX Bioceutical Corporation
NEW YORK and TORONTO, Jan. 18, 2019 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”), (CSE: IAN, OTCQB: ITHUF) and MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC:...
MPX Securityholders Overwhelming Approve Transformational Business Combination with iAnthus
15 janv. 2019 18h00 HE
|
MPX Bioceutical Corporation
NEW YORK and TORONTO, Jan. 15, 2019 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”), (CSE: IAN, OTCQB: ITHUF) and MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC:...
MPX Announces Acquisition of Remaining Interests in Massachusetts Companies
03 janv. 2019 17h00 HE
|
MPX Bioceutical Corporation
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC: MPXEF) announced that on December 28, 2018, it had agreed to acquire certain minority interests in two...
ISS and Glass Lewis Recommend MPX Securityholders Vote in Favour of the Arrangement and MPX Shareholders Vote in Favour of the MPX Continuance and the MPX International Stock Option Plan
03 janv. 2019 08h30 HE
|
MPX Bioceutical Corporation
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE: MPX) (OTC:MPXEF) (the “Company” or “MPX”) is pleased to announce that Institutional Shareholder Services Inc. (“ISS”) and...
iAnthus and MPX Announce Receipt of Interim Court Order
12 déc. 2018 08h56 HE
|
MPX Bioceutical Corporation
NEW YORK and TORONTO, Dec. 12, 2018 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or “the Company”), (CSE: IAN, OTCQB: ITHUF) and MPX Bioceutical Corporation (“MPX”) (CSE: MPX;...
MPX Awarded Four Conditional Retail Dispensary Licenses in Nevada
10 déc. 2018 08h41 HE
|
MPX Bioceutical Corporation
TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) announced that GreenMart NLV, LLC (“GreenMart NLV”), a subsidiary of MPX, has...
MPX Reports Financial Results for Its Fiscal Second Quarter of 2019
29 nov. 2018 16h30 HE
|
MPX Bioceutical Corporation
TORONTO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) today reports financial results for its fiscal second quarter for the three...
MPX Expands Maryland Footprint With Opening of Health for Life White Marsh Dispensary
29 oct. 2018 16h45 HE
|
MPX Bioceutical Corporation
TORONTO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) announced that the Company will open a new Health for Life dispensary in...
iAnthus and MPX Bioceutical Announce Transformational Combination, Expands U.S. Footprint to 10 States
18 oct. 2018 09h51 HE
|
MPX Bioceutical Corporation
NEW YORK and TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”), (CSE: IAN, OTCQX: ITHUF), and MPX Bioceutical Corporation (“MPX”) (CSE: MPX;...
MPX Expands Maryland Footprint With Opening of Baltimore Dispensary
12 oct. 2018 08h30 HE
|
MPX Bioceutical Corporation
TORONTO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) today announced that it opened its new Health for Life dispensary in Baltimore,...